Literature DB >> 30303656

Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.

Li Jiang1,2, Julie Gilbert3, Hugh Langley4, Rahim Moineddin5, Patti A Groome1,2.   

Abstract

INTRODUCTION: Breast cancer is detected through screening or through signs and symptoms. In Canada, mammograms for breast cancer screening are offered in organized programs or independently (opportunistic screening). Province of Ontario breast Diagnostic Assessment Units (DAUs) are facility-based programs that provide coordinated breast cancer diagnostic services, as opposed to usual care, in which the primary care provider arranges the tests and consultations. This study describes breast cancer detection method, diagnostic interval and DAU use across Ontario.
METHODS: The study cohort consisted of 6898 women with invasive breast cancer diagnosed in 2011. We used the Ontario Cancer Registry linked to administrative health care databases. We determined the detection method using the Ontario Breast Screening Program (OBSP) data and physician claims. The diagnostic interval was the time between the initial screen, specialist referral or first diagnostic test and the cancer diagnosis. The diagnostic route (whether through DAU or usual care) was determined based on the OBSP records and biopsy or surgery location. We mapped the diagnostic interval and DAU coverage geographically by women's residence.
RESULTS: In 2011, 36% of Ontario breast cancer patients were screen-detected, with a 48% rate among those aged 50 to 69. The provincial median diagnostic interval was 32 days, with county medians ranging from 15 to 65 days. Provincially, 48.4% were diagnosed at a DAU, and this ranged from zero to 100% across counties.
CONCLUSION: The screening detection rate in age-eligible breast cancer patients was lower than published population-wide screening rates. Geographic mapping of the diagnostic interval and DAU use reveals regional variations in cancer diagnostic care that need to be addressed.

Entities:  

Keywords:  breast neoplasms/diagnosis; cross-sectional studies; diagnostic services; early detection ofzzm321990cancer; early diagnosis; female; health services research

Mesh:

Year:  2018        PMID: 30303656      PMCID: PMC6197611          DOI: 10.24095/hpcdp.38.10.02

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN: 2368-738X            Impact factor:   3.240


  23 in total

1.  Recommendations on screening for breast cancer in average-risk women aged 40-74 years.

Authors:  Marcello Tonelli; Sarah Connor Gorber; Michel Joffres; James Dickinson; Harminder Singh; Gabriela Lewin; Richard Birtwhistle; Donna Fitzpatrick-Lewis; Nicole Hodgson; Donna Ciliska; Mary Gauld; Yan Yun Liu
Journal:  CMAJ       Date:  2011-11-22       Impact factor: 8.262

2.  Body mass and breast cancer. Relationship between method of detection and stage of disease.

Authors:  M J Reeves; P A Newcomb; P L Remington; P M Marcus; W R MacKenzie
Journal:  Cancer       Date:  1996-01-15       Impact factor: 6.860

3.  Survival of women ages 40-49 years with breast carcinoma according to method of detection.

Authors:  C P McPherson; K K Swenson; G Jolitz; C L Murray
Journal:  Cancer       Date:  1997-05-15       Impact factor: 6.860

4.  Factors associated with delays to diagnosis and treatment of breast cancer in women in a Louisiana urban safety net hospital.

Authors:  Donna L Williams; Stephanie Tortu; Jessica Thomson
Journal:  Women Health       Date:  2010-12

5.  Is being diagnosed at a dedicated breast assessment unit associated with a reduction in the time to diagnosis for symptomatic breast cancer patients?

Authors:  Li Jiang; Julie Gilbert; Hugh Langley; Rahim Moineddin; Patti A Groome
Journal:  Eur J Cancer Care (Engl)       Date:  2018-06-05       Impact factor: 2.520

6.  Method of detection and breast cancer survival disparities in Hispanic women.

Authors:  Deirdre A Hill; Andrea Nibbe; Melanie E Royce; Anne Marie Wallace; Huining Kang; Charles L Wiggins; Robert D Rosenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-14       Impact factor: 4.254

7.  Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.

Authors:  Victoria A Kirsh; Anna M Chiarelli; Sarah A Edwards; Frances P O'Malley; Rene S Shumak; Martin J Yaffe; Norman F Boyd
Journal:  J Natl Cancer Inst       Date:  2011-05-03       Impact factor: 13.506

8.  Facilitated "fast track" referral reduces time from abnormal screening mammogram to diagnosis.

Authors:  Marilyn J Borugian; Lisa Kan; Christina C Y Chu; Kathy Ceballos; Karen A Gelmon; Paula B Gordon; Barbara Poole; Scott Tyldesley; Ivo A Olivotto
Journal:  Can J Public Health       Date:  2008 Jul-Aug

9.  Provider delay among patients with breast cancer in Germany: a population-based study.

Authors:  Volker Arndt; Til Stürmer; Christa Stegmaier; Hartwig Ziegler; Annelie Becker; Hermann Brenner
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

10.  Report of the International Workshop on Screening for Breast Cancer.

Authors:  S W Fletcher; W Black; R Harris; B K Rimer; S Shapiro
Journal:  J Natl Cancer Inst       Date:  1993-10-20       Impact factor: 13.506

View more
  6 in total

1.  Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada.

Authors:  Colleen Webber; Marlo Whitehead; Andrea Eisen; Claire M B Holloway; Patti A Groome
Journal:  Breast Cancer Res Treat       Date:  2021-01-24       Impact factor: 4.872

2.  Breast cancer diagnosis and treatment wait times in specialized diagnostic units compared with usual care: a population-based study.

Authors:  C Webber; M Whitehead; A Eisen; C M B Holloway; P A Groome
Journal:  Curr Oncol       Date:  2020-08-01       Impact factor: 3.677

3.  Determining the Cancer Diagnostic Interval Using Administrative Health Care Data in a Breast Cancer Cohort.

Authors:  Patti A Groome; Colleen Webber; Marlo Whitehead; Rahim Moineddin; Eva Grunfeld; Andrea Eisen; Julie Gilbert; Claire Holloway; Jonathan C Irish; Hugh Langley
Journal:  JCO Clin Cancer Inform       Date:  2019-05

4.  Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia.

Authors:  Bader Alshamsan; Kausar Suleman; Naela Agha; Marwa I Abdelgawad; Mashari J Alzahrani; Tusneem Elhassan; Taher Al-Tweigeri; Dahish Ajarim; Adher Alsayed
Journal:  Int J Womens Health       Date:  2022-03-12

5.  Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.

Authors:  Steven Habbous; Esha Homenauth; Andriana Barisic; Sharmilaa Kandasamy; Vicky Majpruz; Katharina Forster; Marta Yurcan; Anna M Chiarelli; Patti Groome; Claire M B Holloway; Andrea Eisen
Journal:  CMAJ Open       Date:  2022-04-05

6.  Changes in primary care provider utilization by phase of care for women diagnosed with breast cancer: a CanIMPACT longitudinal cohort study.

Authors:  K Decker; R Moineddin; C Kendell; R Urquhart; N Biswanger; P Groome; M L McBride; M Winget; M Whitehead; E Grunfeld
Journal:  BMC Fam Pract       Date:  2019-11-21       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.